Biomotion Sciences Ordinary Shares (SLXN) Financials

Balance sheets

01 Sept 202401 June 202401 Mar 202401 Dec 202301 Sept 202301 June 202301 Mar 2023

Total Assets

$3.1 M(+22.3%)$2.5 M(-29.6%)$3.6 M(-31.8%)$5.3 M---

Current Assets

$3.0 M(+31.6%)$2.3 M(-30.7%)$3.3 M(-32.9%)$5.0 M---

Non Current Assets

$40.0 K(-81.0%)$210.0 K(-14.6%)$246.0 K(-11.2%)$277.0 K---

Total Liabilities

$7.7 M(-56.0%)$17.4 M(+2.3%)$17.0 M(-1.6%)$17.3 M---

Current Liabilities

$3.6 M(+51.6%)$2.4 M(+21.8%)$1.9 M(-11.6%)$2.2 M---

Long Term Liabilities

$4.1 M(-72.9%)$15.1 M(-0.2%)$15.1 M(-0.2%)$15.1 M---

Shareholders Equity

-$4.6 M(+74.9%)-$18.3 M(-8.6%)-$16.8 M(-8.7%)-$15.5 M---

Book Value

-$4.6 M(+74.9%)-$18.3 M(-8.6%)-$16.8 M(-8.7%)-$15.5 M---

Working Capital

-$536.0 K(-993.9%)-$49.0 K(-103.5%)$1.4 M(-49.8%)$2.8 M---

Cash And Cash Equivalents

$2.0 M(+16.3%)$1.7 M(-39.0%)$2.8 M(-39.5%)$4.6 M---

Accounts Payable

$799.0 K(+184.3%)$281.0 K(+15.2%)$244.0 K(-23.5%)$319.0 K---

Accounts Receivable

-------

Short Term Debt

$229.0 K(+112.0%)$108.0 K(-1.8%)$110.0 K(-1.8%)$112.0 K---

Long Term Debt

$4.1 M(+50937.5%)$8000.0(-76.5%)$34.0 K(-42.4%)$59.0 K---

Total Debt

$4.3 M(+3617.2%)$116.0 K(-19.4%)$144.0 K(-15.8%)$171.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

-0.9(-9300.0%)-0.0(0%)-0.0(0%)-0.0---

Current Ratio

0.8(-13.3%)1.0(-43.0%)1.7(-24.2%)2.3---

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$41.6 M(-40.2%)-$29.7 M(-5.2%)-$28.2 M(-5.1%)-$26.8 M---

PB Ratio

-0.3------

Income statements

01 Sept 202401 June 202401 Mar 202401 Dec 202301 Sept 202301 June 202301 Mar 2023

EPS

-$18.3(-1024.2%)-$1.6(-7.2%)-$1.5(+20.5%)-$1.9(-119.6%)-$0.9(+52.4%)-$1.8(-113.5%)-$0.9

TTM EPS

-$23.3(-294.1%)-$5.9(+3.3%)-$6.1(-12.1%)-$5.5(-53.8%)-$3.5(-32.4%)-$2.7(-213.6%)-$0.9

Revenue

-------

TTM Revenue

-------

Total Expenses

$8.0 M(+480.2%)$1.4 M(+10.8%)$1.3 M(-27.7%)$1.7 M(+136.4%)$731.0 K(-48.3%)$1.4 M(+75.0%)$808.0 K

Operating Expenses

$8.0 M(+480.2%)$1.4 M(+10.8%)$1.3 M(-27.7%)$1.7 M(+136.4%)$731.0 K(-48.3%)$1.4 M(+75.0%)$808.0 K

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

-$8.0 M(-480.2%)-$1.4 M(-10.8%)-$1.3 M(+27.7%)-$1.7 M(-136.4%)-$731.0 K(+48.3%)-$1.4 M(-75.0%)-$808.0 K

TTM Operating Profit

-$12.4 M(-143.4%)-$5.1 M(+0.6%)-$5.1 M(-9.4%)-$4.7 M(-58.5%)-$3.0 M(-32.9%)-$2.2 M(-175.0%)-$808.0 K

Operating Margin

-------

Net Income

-$11.9 M(-705.1%)-$1.5 M(-7.2%)-$1.4 M(+20.5%)-$1.7 M(-119.6%)-$787.0 K(+52.4%)-$1.7 M(-113.6%)-$774.0 K

TTM Net Income

-$16.4 M(-206.4%)-$5.4 M(+3.3%)-$5.5 M(-12.1%)-$4.9 M(-53.8%)-$3.2 M(-32.4%)-$2.4 M(-213.6%)-$774.0 K

Net Margin

-------

EBIT

-$8.0 M(-441.1%)-$1.5 M(-18.8%)-$1.3 M(+27.7%)-$1.7 M(-136.4%)-$731.0 K(+60.8%)-$1.9 M(-130.6%)-$808.0 K

TTM EBIT

-$12.5 M(-140.6%)-$5.2 M(+6.8%)-$5.6 M(-8.6%)-$5.1 M(-50.8%)-$3.4 M(-27.4%)-$2.7 M(-230.6%)-$808.0 K

EBITDA

-$8.0 M(-442.2%)-$1.5 M(-19.0%)-$1.2 M(+27.9%)-$1.7 M(-138.8%)-$721.0 K(+61.0%)-$1.8 M(-133.2%)-$793.0 K

TTM EBITDA

-$12.5 M(-141.3%)-$5.2 M(+6.7%)-$5.5 M(-8.8%)-$5.1 M(-51.2%)-$3.4 M(-27.3%)-$2.6 M(-233.2%)-$793.0 K

Selling, General & Administrative Expenses

$4.8 M(+683.8%)$612.0 K(+117.8%)$281.0 K(-39.6%)$465.0 K(+150.0%)$186.0 K(+12.7%)$165.0 K(+47.3%)$112.0 K

TTM SG&A

$6.2 M(+298.6%)$1.5 M(+40.8%)$1.1 M(+18.2%)$928.0 K(+100.4%)$463.0 K(+67.2%)$277.0 K(+147.3%)$112.0 K

Depreciation And Amortization

$22.0 K(+214.3%)$7000.0(-12.5%)$8000.0(+33.3%)$6000.0(-40.0%)$10.0 K(-28.6%)$14.0 K(-6.7%)$15.0 K

TTM D&A

$43.0 K(+38.7%)$31.0 K(-18.4%)$38.0 K(-15.6%)$45.0 K(+15.4%)$39.0 K(+34.5%)$29.0 K(+93.3%)$15.0 K

Interest Expense

-$2000.0---$3000.0-

TTM Interest Expense

-$2000.0---$3000.0-

Income Tax

$2000.0(0%)$2000.0(-60.0%)$5000.0(-16.7%)$6000.0(0%)$6000.0(-40.0%)$10.0 K(0%)$10.0 K

TTM Income Tax

$15.0 K(-21.1%)$19.0 K(-29.6%)$27.0 K(-15.6%)$32.0 K(+23.1%)$26.0 K(+30.0%)$20.0 K(+100.0%)$10.0 K

PE Ratio

-------

PS Ratio

-------

Cashflow statements

01 Sept 202401 June 202401 Mar 202401 Dec 202301 Sept 202301 June 202301 Mar 2023

Cash From Operations

-$2.7 M(-149.1%)-$1.1 M(+39.2%)-$1.8 M(-39.4%)-$1.3 M(-83.5%)-$685.0 K(+59.1%)-$1.7 M(-84.0%)-$911.0 K

TTM CFO

-$6.7 M(-41.4%)-$4.8 M(+11.4%)-$5.4 M(-18.6%)-$4.5 M(-38.4%)-$3.3 M(-26.5%)-$2.6 M(-184.0%)-$911.0 K

Cash From Investing

-$16.0 K(-100.0%)$0.0(+100.0%)-$6000.0(-50.0%)-$4000.0(-105.6%)$72.0 K(+3700.0%)-$2000.0(-100.4%)$507.0 K

TTM CFI

-$26.0 K(-141.9%)$62.0 K(+3.3%)$60.0 K(-89.5%)$573.0 K(-0.7%)$577.0 K(+14.3%)$505.0 K(-0.4%)$507.0 K

Cash From Financing

$2.9 M(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$522.0 K(+100.0%)$0.0

TTM CFF

$2.9 M(+100.0%)$0.0(-100.0%)$522.0 K(0%)$522.0 K(0%)$522.0 K(0%)$522.0 K(+100.0%)$0.0

Free Cash Flow

-$2.7 M(-150.6%)-$1.1 M(+39.4%)-$1.8 M(-39.4%)-$1.3 M(-82.5%)-$691.0 K(+58.8%)-$1.7 M(-84.2%)-$911.0 K

TTM FCF

-$6.8 M(-41.4%)-$4.8 M(+11.4%)-$5.4 M(-18.6%)-$4.5 M(-38.5%)-$3.3 M(-26.7%)-$2.6 M(-184.2%)-$911.0 K

CAPEX

-------

TTM CAPEX

-------

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------